Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research focused on Docking (animal) and Pharmacology, with related work in In vitro, Computational biology, Lung cancer. Notable publications include 'A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia', 'Exploring the Mechanism of Xihuang Pill's Anti-Osteosarcoma Effects Through Network Pharmacology, in Vivo and in Vitro Experiments, and Molecular Docking Verification', and 'Isorhapontigenin is a novel potential therapeutic agent for lung cancer： evidence from network pharmacology, bioinformatics, molecular docking and in vitro experiments'.
Exploring the Mechanism of Xihuang Pill's Anti-Osteosarcoma Effects Through Network Pharmacology, in Vivo and in Vitro Experiments, and Molecular Docking Verification
Isorhapontigenin is a novel potential therapeutic agent for lung cancer： evidence from network pharmacology, bioinformatics, molecular docking and in vitro experiments
Unveiling Isorhapontigenin’s therapeutic potential in lung cancer via integrated network pharmacology, molecular docking, and experimental validation
A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia